|
Volumn 44, Issue 1 SUPPL., 2001, Pages
|
A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
ANTIMIGRAINE AGENT;
ASTEMIZOLE;
CORTICOSTEROID;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HISTAMINE H2 RECEPTOR ANTAGONIST;
IMMUNOSUPPRESSIVE AGENT;
PREDNISONE;
TACROLIMUS;
TERFENADINE;
ADOLESCENT;
ARTICLE;
ATOPIC DERMATITIS;
BLISTER;
BODY SURFACE;
BURN;
CHICKENPOX;
CHILD;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
MALE;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SCHOOL CHILD;
TREATMENT CONTRAINDICATION;
TREATMENT OUTCOME;
|
EID: 0035164433
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1067/mjd.2001.109813 Document Type: Article |
Times cited : (318)
|
References (26)
|